Indegene (INDGN) M&A announcement summary

Deal rationale and strategic fit

• Adds BioPharm’s brand-side omnichannel campaign execution, precision media strategy, planning, buying and targeted HCP engagement to complementary enterprise reach, strategy and creative capabilities.

• Combines data, technology, talent and client access to strengthen AI-enabled life sciences sales, marketing and commercialization.

• BioPharm serves 17 of the top 25 global pharma companies and brings 60+ clients.

• Tandem and Invisage data expand physician profiles from 1.8M to 3M, with richer oncology, rare disease and ophthalmology coverage.

• BioPharm adds a proprietary network of 3M+ healthcare decision-makers and campaign response data spanning 300M+ exposure events and 15M+ engagements.

Financial terms and conditions

• Acquired 100% of BioPharm Parent Holding and subsidiaries BioPharm Communications LLC and Addressable Health LLC for $104M, debt-free and cash-free, subject to excess cash and working-capital adjustments.

• Guaranteed consideration is $77M: $65M paid at closing and $12M deferred to March 2026; earnouts are up to $8M for CY2025 and $19M for CY2026 performance.

• Earnouts also depend on the CY2027 order book; 15%-20% YoY growth supports full payout, with lower growth reducing payout pro rata.

• CY2024 unaudited results: $38.1M gross revenue, $29.2M net revenue and $7.9M EBITDA, a ~27% margin on net revenue.

• Funded from cash on hand and internal accruals; guaranteed consideration was stated at ~9.8x trailing CY2024 EBITDA, while total valuation including earnouts was estimated at 9x-9.5x EBITDA; EPS accretion expected beyond 5-6 quarters.

Synergies and expected cost savings

• Expected annual cost synergies of ~$1M after integration from consolidated data purchases, licensing, role consolidation and future offshoring.

• Cross-selling can pair brand-side campaign execution with enterprise reach, brand strategy and content services across shared pharma clients, brands, channels and data assets.

• BioPharm capabilities can scale into enterprise programmatic centers of excellence and media hubs, expanding brand wallet share through direct and indirect channels.

• Combined data assets are intended to improve Media ROI and enable more effective agentic operations.